Drug Detail

Information about

Generic Name
IND
Brand Name (US)
Manufacturer
Drug Type
Delivery
Approval Status
Indications
Overall Strategy	GIST Tumor Based
Strategy	Block tumor blood vessel growth
Drug Category	VEGFR inhibitor (TKI)

This is a generic placeholder for a trial that does not specify which angiogenesis inhibitor will be used.